American Vanguard Corp Dossier - Source-backed chat

American Vanguard Corp

AVDNYSE

SectorMaterials

IndustryFertilizers & Agricultural Chemicals

Beta (adjusted)1.29

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $1.75Price as of 30 Sep 2026

Data confidenceNot applicable

Market Cap $51.6M

Enterprise Value $248.3M

Shares Outstanding 28.8M diluted

Moat Rating None

Next Earnings Date10 Nov 2026

Last ex-dividend26 Jun 2024

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

American Vanguard Corporation (AVD) is executing a robust operational turnaround under its 'Simplify, Prioritize and Deliver' strategy. Despite a challenging global agricultural backdrop, the company demonstrated strong domestic momentum in Q1 2026, with U.S. crop sales up 17% and gross margins expanding by 500 basis points to 31%. The successful securing of a first-lien term loan with Centerbridge Partners in March 2026 has stabilized the capital structure, providing a solid liquidity cushion ($71 million cash on hand) to fund strategic growth. With customer destocking largely completed and a clear path toward manufacturing rationalization (shifting production from Los Angeles to Alabama to yield $4 million in annualized savings), AVD is well-positioned to capture high-margin specialty and biological opportunities.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

Persistent international headwinds, including prolonged drought in Australia and slow inventory normalization in Mexico, drag down overall sales. Farmers adopt an increasingly conservative just-in-time purchasing pattern due to geopolitical uncertainty, squeezing domestic margins. High leverage and elevated interest expenses under the new term loan structure limit free cash flow generation.

Base CaseCentral scenario

The company successfully achieves its full-year 2026 guidance, delivering net sales between $530 million and $550 million and adjusted EBITDA between $44 million and $48 million. Domestic crop and specialty sales continue to offset near-term international timing headwinds. Operational streamlining, including the Los Angeles facility rationalization, drives gross margins toward the low-30s and supports progress toward the long-term 15% EBITDA margin target.

Bull CaseUpside scenario

American Vanguard's bull case centers on its business transformation initiatives, including the rationalization of its Los Angeles manufacturing facility to Axis, Alabama, which is expected to generate at least $4 million in annualized savings. Additionally, the company's robust product pipeline (targeting 50 new product launches over five years to generate $100 million in annualized revenue by 2030) and its expansion in Green Solutions and international markets provide a strong foundation for margin expansion and long-term profitability.

Scenarios reflect our research view at the research date.

Key Investment Merits

Strong domestic crop sales growth (+17% in Q1 2026) driven by robust demand for core herbicide and insecticide brands.
Significant gross margin expansion (+500 bps YoY to 31% in Q1 2026) reflecting better product mix and procurement efficiencies.
Stabilized capital structure and improved liquidity ($71 million cash) following the Centerbridge Partners term loan agreement.
Clear operational efficiency roadmap, including manufacturing rationalization expected to deliver at least $4 million in annualized savings.

Key Investment Risks

High leverage and elevated interest expenses, with average debt levels keeping financial risk elevated.
Geographic concentration and exposure to volatile international agricultural markets (e.g., Brazil, India, Mexico, Australia).
Farmer purchasing behavior shifting toward conservative, just-in-time buying patterns amid macroeconomic uncertainty.

Thesis Invalidation Triggers

Adjusted EBITDA falling below the lower bound of 2026 guidance ($44 million).
Failure to realize the projected $4 million in annualized savings from the Los Angeles facility rationalization.
A material increase in net debt or failure to meet covenants under the Centerbridge Partners credit facility.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.